Company
Board of Directors
Bernhard Ehmer
Chairman of the Board of Directors
Mr. Bernhard Ehmer was re-elected as Chairman of the Board of Directors in May 2019. He currently se… Read morerves as CEO of Biotest AG, and brings more than 30 years of experience from the global pharmaceutical industry to the Company, mainly within oncology.
Ron Eastman, MBA
Board member
Ron Eastman has been a member of the Board since 2015 and re-elected in May 2019.
Mr… Read more. Eastman is Managing Director of EW Healthcare Partners.
He serves as Chairman of EluSys Therapeutics Inc, and is a member of the board of Corium International and IntegenX.
Mr. Eastman's special competencies with relevance for Symphogen include executive and board experience with special focus on building healthcare businesses.
Mr… Read more. Eastman is Managing Director of EW Healthcare Partners.
He serves as Chairman of EluSys Therapeutics Inc, and is a member of the board of Corium International and IntegenX.
Mr. Eastman's special competencies with relevance for Symphogen include executive and board experience with special focus on building healthcare businesses.
Peter Haahr
Board member
Mr. Peter Haahr was re-elected member of the Board in May 2019. He currently serves as CFO of Novo H… Read moreoldings.
Mads Krogsgaard Thomsen
Board member
Mr. Mads Krogsgaard Thomsen was re-elected member of the Board in May 2019. He currently serves as E… Read moreVP and Chief Science Officer of Novo Nordisk A/S
Søren Lemonius
Board member
Mr. Søren Lemonius was re-elected member of the Board in May 2019. He currently serves as Managing … Read morePartner in the Life Science group of Sunstone Capital and is one of its three co-founders.